Sterile, single-use intra-articular hyaluronic acid gels for viscosupplementation in osteoarthritis and joint disorders. Four grades, developed and manufactured by SKY Biotechnology.
Intraarticular implant gels are injectable viscoelastic devices used to supplement the synovial fluid of joints affected by osteoarthritis and degenerative disorders. By supporting lubrication and shock absorption, they are intended to improve joint mobility and comfort. SkyVisc covers four grades on a common concentration range of 10–30 mg/mL: SkyVisc Pure (sodium hyaluronate alone), SkyVisc + (with L-proline), SkyVisc GGP (with L-proline, glycine and N-acetyl glucosamine) and SkyVisc Cross (the cross-linked grade) — three linear gels and one cross-linked, from a single source. As the flagship line of SKY Biotechnology, these products are developed and produced in-house.
Four grades of intra-articular hyaluronic acid gel — three linear, one cross-linked.
Highly purified sodium hyaluronate with no additives. Linear gel. Pre-filled syringe from 1 to 5 mL, in concentrations from 10 to 30 mg/mL.
Hyaluronic acid with L-proline, an amino acid that is a structural component of collagen. Linear gel. Pre-filled syringe (1–5 mL) or flacon (5 or 10 mL), in concentrations from 10 to 30 mg/mL.
Hyaluronic acid with L-proline, glycine and N-acetyl glucosamine — the constituents behind the GGP name (Glucosamine, Glycine, Proline). Linear gel. Pre-filled syringe (1–5 mL) or flacon (5 or 10 mL), in concentrations from 10 to 30 mg/mL.
Highly purified cross-linked hyaluronic acid of bacterial origin. Cross-linking bonds the polymer chains into a network that maintains its shape longer and slows disintegration. One injection per treatment. Pre-filled syringe (1–5 mL), 10 to 30 mg/mL.
| SkyVisc Pure | SkyVisc + | SkyVisc GGP | SkyVisc Cross | |
|---|---|---|---|---|
| Hyaluronic acid | 10 – 30 mg/mL | 10 – 30 mg/mL | 10 – 30 mg/mL | 10 – 30 mg/mL |
| Concentrations | 10 / 14 / 15 / 20 / 24 / 25 / 30 mg/mL | 10 / 14 / 15 / 20 / 24 / 25 / 30 mg/mL | 10 / 14 / 15 / 20 / 24 / 25 / 30 mg/mL | 10 / 14 / 15 / 20 / 24 / 25 / 30 mg/mL |
| Additional components | — | L-proline | L-proline, glycine, N-acetyl glucosamine | — |
| Bonding | Linear | Linear | Linear | Cross-linked |
| Syringe | 1 / 2 / 2.5 / 3 / 4 / 5 mL | 1 / 2 / 2.5 / 3 / 4 / 5 mL | 1 / 2 / 2.5 / 3 / 4 / 5 mL | 1 / 2 / 2.5 / 3 / 4 / 5 mL |
| Flacon | — | 5 / 10 mL | 5 / 10 mL | — |
| Formulation | Sodium hyaluronate in buffer (sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium chloride) — with L-proline in SkyVisc +; with L-proline, glycine and N-acetyl glucosamine in SkyVisc GGP. | |||
All SkyVisc grades: sterile viscoelastic solution, single use. Shelf life: 2 years. Storage: 2–25 °C — no cold chain required. CE marked.
Per the Instructions for Use. Intended for use by qualified healthcare professionals.
Technical specifications, regulatory documentation and catalogs are available to qualified partners on request.
Product information is provided for healthcare professionals, distributors and business partners and does not constitute medical advice. Availability, specifications and regulatory status may vary by country.